NCT04869137lenvatinibpembrolizumabMerkel cell carcinomaMCCimmunotherapy
…these promising findings is warranted.Trial registration number NCT04869137.…
1articles mentioning funders
1funder mentions
1distinct funders extracted
0%of mentions human-reviewed
Active filtersEntity: NCT04869137 ×
NCT04869137
This funder is selected. Its supporting articles are shown below.